CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.49

EPS Forecast

$5.83

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
HALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncREPLReplimune Group IncRGENRepligen CorpNVAXNovavax IncTECHBio-techne CorpMRNAModerna IncDNLIDenali Therapeutics Inc